On the public citation graph

Characterisation of antigenic MHC Class I-restricted T cell epitopes in the glycoprotein of Ebolavirus

https://doi.org/10.1101/494021
0 signed · 54 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2016.4218openalex-snapshot
Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
inferredcites →https://doi.org/10.1007/s00251-008-0341-zopenalex-snapshot
NetMHCpan, a method for MHC class I binding prediction beyond humans
inferredcites →https://doi.org/10.1007/s00705-010-0814-xopenalex-snapshot
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
inferredcites →https://doi.org/10.1016/0140-6736(90)90737-popenalex-snapshot
Preliminary report: isolation of Ebola virus from monkeys imported to USA
inferredcites →https://doi.org/10.1016/j.cell.2015.12.044openalex-snapshot
Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1
inferredcites →https://doi.org/10.1016/j.celrep.2017.08.023openalex-snapshot
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
inferredcites →https://doi.org/10.1016/j.ebiom.2017.03.045openalex-snapshot
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
inferredcites →https://doi.org/10.1016/j.jbi.2014.11.003openalex-snapshot
An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
inferredcites →https://doi.org/10.1016/j.jim.2016.01.014openalex-snapshot
T-cell libraries allow simple parallel generation of multiple peptide-specific human T-cell clones
inferredcites →https://doi.org/10.1016/j.jmb.2007.05.022openalex-snapshot
Inference of Macromolecular Assemblies from Crystalline State
inferredcites →https://doi.org/10.1016/j.meegid.2015.10.012openalex-snapshot
Computational elucidation of potential antigenic CTL epitopes in Ebola virus
inferredcites →https://doi.org/10.1016/j.sbi.2009.05.004openalex-snapshot
Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it
inferredcites →https://doi.org/10.1016/j.virol.2003.09.016openalex-snapshot
Identification of murine T-cell epitopes in Ebola virus nucleoprotein
inferredcites →https://doi.org/10.1016/j.virol.2006.09.042openalex-snapshot
Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes
inferredcites →https://doi.org/10.1016/j.virol.2015.03.029openalex-snapshot
Ebolavirus is evolving but not changing: No evidence for functional change in EBOV from 1976 to the 2014 outbreak
inferredcites →https://doi.org/10.1016/s0140-6736(10)60667-8openalex-snapshot
Ebola haemorrhagic fever
inferredcites →https://doi.org/10.1016/s0140-6736(15)61117-5openalex-snapshot
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
inferredcites →https://doi.org/10.1016/s0140-6736(16)32621-6openalex-snapshot
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
inferredcites →https://doi.org/10.1016/s1473-3099(15)00154-1openalex-snapshot
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
inferredcites →https://doi.org/10.1038/cr.2009.6openalex-snapshot
DOG 1.0: illustrator of protein domain structures
inferredcites →https://doi.org/10.1038/mt.2016.3openalex-snapshot
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection
inferredcites →https://doi.org/10.1038/nature07082openalex-snapshot
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
inferredcites →https://doi.org/10.1038/nature13777openalex-snapshot
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
inferredcites →https://doi.org/10.1038/nature17949openalex-snapshot
Unique human immune signature of Ebola virus disease in Guinea
inferredcites →https://doi.org/10.1038/nature18615openalex-snapshot
Toremifene interacts with and destabilizes the Ebola virus glycoprotein
inferredcites →https://doi.org/10.1038/nm.2447openalex-snapshot
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
inferredcites →https://doi.org/10.1038/nm1461openalex-snapshot
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
inferredcites →https://doi.org/10.1038/nrmicro2129openalex-snapshot
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
inferredcites →https://doi.org/10.1056/nejm198307073090103openalex-snapshot
Cytotoxic T-Cell Immunity to Influenza
inferredcites →https://doi.org/10.1056/nejmoa1404505openalex-snapshot
Emergence of Zaire Ebola Virus Disease in Guinea
inferredcites →https://doi.org/10.1056/nejmoa1411627openalex-snapshot
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
inferredcites →https://doi.org/10.1056/nejmoa1502924openalex-snapshot
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
inferredcites →https://doi.org/10.1073/pnas.1007270107openalex-snapshot
Cross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses
inferredcites →https://doi.org/10.1073/pnas.1105624108openalex-snapshot
Systematic identification of immunodominant CD8 + T-cell responses to influenza A virus in HLA-A2 individuals
inferredcites →https://doi.org/10.1073/pnas.1414164111openalex-snapshot
Structures of protective antibodies reveal sites of vulnerability on Ebola virus
inferredcites →https://doi.org/10.1073/pnas.1502619112openalex-snapshot
Human Ebola virus infection results in substantial immune activation
inferredcites →https://doi.org/10.1073/pnas.1806200115openalex-snapshot
Analysis of CD8 + T cell response during the 2013–2016 Ebola epidemic in West Africa
inferredcites →https://doi.org/10.1093/bioinformatics/btn128openalex-snapshot
Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers
inferredcites →https://doi.org/10.1093/infdis/jiw508openalex-snapshot
Comprehensive characterization of cellular immune responses following Ebola virus infection
inferredcites →https://doi.org/10.1093/infdis/jiy639openalex-snapshot
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
inferredcites →https://doi.org/10.1111/sji.12425openalex-snapshot
B and T Cell Epitope‐Based Peptides Predicted from Evolutionarily Conserved and Whole Protein Sequences of Ebola Virus as Vaccine Targets
inferredcites →https://doi.org/10.1126/science.1172705openalex-snapshot
Discovery of Swine as a Host for the Reston ebolavirus
inferredcites →https://doi.org/10.1126/science.1259657openalex-snapshot
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
inferredcites →https://doi.org/10.1126/science.aaa5646openalex-snapshot
Mutation rate and genotype variation of Ebola virus from Mali case sequences
inferredcites →https://doi.org/10.1126/science.aad5224openalex-snapshot
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
inferredcites →https://doi.org/10.1126/science.aad6117openalex-snapshot
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
inferredcites →https://doi.org/10.1126/scitranslmed.3006608openalex-snapshot
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
inferredcites →https://doi.org/10.1128/jvi.76.12.6408-6412.2002openalex-snapshot
Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody
inferredcites →https://doi.org/10.1155/2017/2680160openalex-snapshot
Fundamentals and Methods for T- and B-Cell Epitope Prediction
inferredcites →https://doi.org/10.1186/1743-422x-9-111openalex-snapshot
Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins
inferredcites →https://doi.org/10.1371/journal.pone.0096360openalex-snapshot
Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus
inferredcites →https://doi.org/10.2217/fvl.09.56openalex-snapshot
Ebolavirus Glycoprotein Structure and Mechanism of Entry
inferredcites →https://doi.org/10.4049/jimmunol.180.4.2174openalex-snapshot
Induction of Broad Cross-Subtype-Specific HIV-1 Immune Responses by a Novel Multivalent HIV-1 Peptide Vaccine in Cynomolgus Macaques

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.37349/ei.2024.00139openalex-snapshot
Filoviridae: insights into immune responses to Ebola virus
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.